Status | Study |
RECRUITING |
Study Name: Homologous Re-infection With Dengue 1 or Dengue 3 Condition: Dengue Date: 2023-07-21 Interventions: Dengue subtype 1 Challenge Virus (DENV-1) strain 45AZ5 |
NOT_YET_RECRUITING |
Study Name: Identification of Risk Determinants of Dengue Transmission Through Landscape Analysis Condition: Date: 2023-05-26 Interventions: A probabilistic risk model will be generated based on the variables of different natures used and maps will be built to identify the areas of greatest |
RECRUITING |
Study Name: Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4) Condition: Dengue Date: 2022-02-09 Interventions: Low dose 0.5 mL of the challenge strain is administered subcutaneously in the triceps region of the arm on Study Day 0. |
Recruiting |
Study Name: Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age Condition: Dengue Date: 2016-08-22 Interventions: Biological: TetraVax-DV TV005 |
Recruiting |
Study Name: Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30 Condition: Dengue Date: 2016-08-16 Interventions: Biological: TetraVax-DV-TV005 |
Completed |
Study Name: Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus Vaccine Condition: Dengue Date: 2016-02-16 Interventions: Biological: rDEN3∆30 10^ |
Active, not recruiting |
Study Name: Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh Condition: Dengue Date: 2016-02-05 Interventions: Biological: TV005 vaccine Deli |
Recruiting |
Study Name: The Use of Biomarkers in Predicting Dengue Outcome Condition: Dengue Date: 2015-11-09 |
Recruiting |
Study Name: A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia Condition: Dengue Date: 2015-10-05 Interventions: Procedure: Blood sample collection Blood samples will be collected during the Suspected Dengue First Vis |
Completed |
Study Name: Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005) Condition: Dengue Date: 2015-05-19 Interventions: Biological: V180 Tetravalent r |